Needham Maintains Buy on Medtronic, Raises Price Target to $114
Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $101 to $114.
Read original at benzingaStocks · News reference
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst ratings for high-yielding stocks and recent news on Bristol-Myers Squibb, GSK, and Medtronic PLC on Benzinga's Analyst Stock Ratings page.Investors turn to dividend-yielding stocks in turbulent markets. Check out analyst ratings and news for high-yielding stocks on Benzinga's Analyst Stock Ratings page.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 28, 2026, 11:38 AM
- Checked
- Jul 28, 2026, 11:38 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Mizuho Maintains Outperform on NVIDIA, Raises Price Target to $315
Mizuho analyst Vijay Rakesh maintains NVIDIA (NASDAQ:NVDA) with a Outperform and raises the price target from $300 to $315.
Read original at benzinga'Anthropic Considers Letting Shareholders Sell In IPO, Departing from SpaceX Playbook' - The Information
https://www.theinformation.com/articles/anthropic-considers-letting-shareholders-sell-ipo-departing-spacex-playbook
Read original at benzingaNvidia Stock 'Valuation Remains Conservative': Early 2028 Guidance Has Analysts Increasing Price Targets
Nvidia's early look at 2028 guidance surprises analysts and has them looking to even more upside in the stock.
Read original at benzingaJP Morgan Maintains Overweight on NVIDIA, Raises Price Target to $320
JP Morgan analyst Harlan Sur maintains NVIDIA (NASDAQ:NVDA) with a Overweight and raises the price target from $280 to $320.
Read original at benzinga